0.9355
Finanzdaten der Cardiff Oncology Inc-Aktie (CRDF)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
153.66%
0.104
|
0.041 | 0.243 | 0.12 | 0.121 |
| Operating Expenses |
24.61%
9.719
|
12.89 | 8.07 | 12.09 | 14.90 |
| Operating Income/Loss |
25.18%
-9.615
|
-12.85 | -7.827 | -11.97 | -14.78 |
| Nonoperating Income/Loss |
24.16%
0.383
|
0.505 | 0.611 | 0.716 | 0.834 |
|
|
25.22%
-9.232
|
-12.35 | -7.216 | -11.26 | -13.94 |
| Preferred Stock Dividends And Other Adjustments |
0.00%
0.006
|
0.006 | 0.007 | 0.006 | 0.006 |
| Basic Average Shares |
0.07%
68.40
|
68.35 | - | 66.88 | 66.53 |
| Diluted Average Shares |
0.07%
68.40
|
68.35 | - | 66.88 | 66.53 |
| Basic Earnings Per Share |
22.22%
-0.14
|
-0.18 | - | -0.17 | -0.21 |
| Diluted Earnings Per Share |
22.22%
-0.14
|
-0.18 | - | -0.17 | -0.21 |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):